Sander Dale A.'s Form 4 filing
Humacyte, Inc. (HUMA) · filed Dec 19, 2022
- Accession no.
- 0001818382-22-000224
- Filed
- Dec 19, 2022
- Trade date
- Dec 13-16, 2022
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $52.0K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sander Dale A.CIK 0001878193 | Officer (CFO and Chief Corp. Deve. Off.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | Common Stock | WInheritanceAcquired | +600 | $0.00 | $0 | 600 | Indirect | |
| Dec 16, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $2.60 | +$52,000 | 20,600 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.